InnoCore Pharmaceuticals will participate in the Nordic Life Science Days (NLSDays) 2026, held on the 8th and 9th September 2026 in Stockholm, Sweden, the Nordic region’s largest partnering conference for the global life‑science industry. Hosted by SwedenBIO, NLSDays convenes the full ecosystem—biotech and medtech innovators, pharma, investors, academia, and international delegations—through high‑value partnering tools and focused sessions designed to accelerate collaboration and growth.
At the NLSDays, InnoCore Pharmaceuticals will spotlight its polymer‑based, long‑acting injectable platforms and controlled‑release formulation expertise—solutions designed to improve therapeutic profiles, enhance patient adherence, and enable scalable development pathways for partners across biologics and small molecules. Our objectives in Stockholm are to deepen scientific dialogues with pharma and biotech founders and explore how our differentiated drug‑delivery technologies that can speed up the time‑to‑clinic and de‑risk development.
If you’re attending the NLSDays 2026, we’d welcome a conversation—whether you’re scouting controlled‑release options for a fragile API or exploring long‑acting profiles for lifecycle management. Connect with Vincent and Martin at the venue or contact us through the contact form below.
"*" indicates required fields